Search

everythinglearnresearchcommunity

for

Search:↓

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Many alopecia patients have undetected thyroid abnormalities that can be found through physical exams.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

People with alopecia have a higher risk of thyroid cancer.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Lupus can cause hair loss and nail changes, with treatments available for both.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.